Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.22 USD
707.96 M USD
30.05 B USD
3.15 B
About TAKEDA PHARMACEUTICAL CO LTD
Sector
Industry
CEO
Christophe Weber
Website
Headquarters
Osaka
Founded
1781
FIGI
BBG000LF8708
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
TKPH5010048
Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060Yield to maturity
7.25%
Maturity date
Jul 9, 2060
TKPH5010047
Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050Yield to maturity
7.22%
Maturity date
Jul 9, 2050
TKPH5010046
Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040Yield to maturity
6.68%
Maturity date
Jul 9, 2040
TKPH5841810
Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064Yield to maturity
6.24%
Maturity date
Jul 5, 2064
TKPH5841809
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054Yield to maturity
6.08%
Maturity date
Jul 5, 2054
TKPH5841808
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044Yield to maturity
6.01%
Maturity date
Jul 5, 2044
TKPH5841807
Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034Yield to maturity
5.32%
Maturity date
Jul 5, 2034
TKPH5010045
Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030Yield to maturity
5.04%
Maturity date
Mar 31, 2030
See all TAK bonds